Calcium channel blocker reduces airway remodeling in severe asthma: A proof-of-concept study

American Journal of Respiratory and Critical Care Medicine

Volumn 191, Issue 8, 2015, Pages 876-883

  Girodet, Pierre Olivier ^a,b   Dournes, Gäel ^a,b   Thumerel, Matthieu ^a,b   Begueret, Hugues ^b   Dos Santos, Pierre ^a,b   Ozier, Annaig ^a,b   Dupin, Isabelle ^a   Trian, Thomas ^a   Montaudon, Michel ^a,b   Laurent, François ^a,b   Marthan, Roger ^a,b   Berger, Patrick ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

Author keywords

Asthma; Exacerbation; Mitochondria; Remodeling; Smooth muscle

Indexed keywords

CORTICOSTEROID; GALLOPAMIL; PLACEBO; SALBUTAMOL; CALCIUM CHANNEL BLOCKING AGENT;

ADULT; AIRWAY REMODELING; ARTICLE; ASTHMA; BLOOD PRESSURE; BRONCHUS MUSCLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MONITORING; DRUG SAFETY; FEMALE; FIBEROPTIC BRONCHOSCOPY; FOLLOW UP; HEART RATE; HUMAN; HUMAN TISSUE; MALE; PR INTERVAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; BRONCHOGRAPHY; BRONCHOSCOPY; DRUG EFFECTS; FIBER OPTICS; MIDDLE AGED; PROCEDURES; RADIOGRAPHY; TREATMENT OUTCOME;

AIRWAY REMODELING; ASTHMA; BRONCHOGRAPHY; BRONCHOSCOPY; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; FEMALE; FIBER OPTIC TECHNOLOGY; FOLLOW-UP STUDIES; GALLOPAMIL; HUMANS; MALE; MIDDLE AGED; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84927799855     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201410-1874OC     Document Type: Article

References (27)

1. Currie GP, Douglas JG, Heaney LG. Difficult to treat asthma in adults. BMJ 2009;338:b494.
2. Martinez FD, Vercelli D. Asthma. Lancet 2013;382:1360-1372.
3. Kaminska M, Foley S, Maghni K, Storness-Bliss C, Coxson H, Ghezzo H, Lemiere C, Olivenstein R, Ernst P, Hamid Q, et al. Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. J Allergy Clin Immunol 2009;124:45-51, e41-44.
4. Ramos-Barbón D, Fraga-Iriso R, Brienza NS, Montero-Martínez C, Verea-Hernando H, Olivenstein R, Lemiere C, Ernst P, Hamid QA, Martin JG. T cells localize with proliferating smooth muscle alpha-actin1 cell compartments in asthma. Am J Respir Crit Care Med 2010;182:317-324.
5. Johnson PR, Roth M, Tamm M, Hughes M, Ge Q, King G, Burgess JK, Black JL. Airway smooth muscle cell proliferation is increased in asthma. Am J Respir Crit Care Med 2001;164:474-477.
6. Girodet PO, Ozier A, Bara I, Tunon de Lara JM, Marthan R, Berger P. Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention. Pharmacol Ther 2011;130:325-337.
7. Roth M, Johnson PR, Borger P, Bihl MP, Rüdiger JJ, King GG, Ge Q, Hostettler K, Burgess JK, Black JL, et al. Dysfunctional interaction of C/EBPalpha and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N Engl J Med 2004; 351:560-574.
8. Trian T, Benard G, Begueret H, Rossignol R, Girodet PO, Ghosh D, Ousova O, Vernejoux JM, Marthan R, Tunon-de-Lara JM, et al. Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma. J Exp Med 2007;204:3173-3181.
9. Global Initiative for Asthma. Global strategy for asthma management and prevention. 2012 [accessed 2015 Jan 23]. Available from: http://www.ginasthma.org
10. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, et al. Guidelines for methacholine and exercise challenge testing-1999. Am J Respir Crit Care Med 2000;161:309-329.
11. American Thoracic Society. Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. Am J Respir Crit Care Med 2000;162:2341-2351.
12. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:1715-1721.
13. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moncada S, et al. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 2003;299:896-899.
14. Berger P, Lavallée J, Rouiller R, Laurent F, Marthan R, Tunon-de-Lara JM. Assessment of bronchial inflammation using an automated cell recognition system based on colour analysis. Eur Respir J 1999;14:1394-1402.
15. Bara I, Ozier A, Girodet PO, Carvalho G, Cattiaux J, Begueret H, Thumerel M, Ousova O, Kolbeck R, Coyle AJ, et al. Role of YKL-40 in bronchial smooth muscle remodeling in asthma. Am J Respir Crit Care Med 2012;185:715-722.
16. Berger P, Perot V, Desbarats P, Tunon-de-Lara JM, Marthan R, Laurent F. Airway wall thickness in cigarette smokers: quantitative thinsection CT assessment. Radiology 2005;235:1055-1064.
17. Montaudon M, Berger P, de Dietrich G, Braquelaire A, Marthan R, Tunon-de-Lara JM, Laurent F. Assessment of airways with threedimensional quantitative thin-section CT: in vitro and in vivo validation. Radiology 2007;242:563-572.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307-310.
19. Bland JM, Altman DG. Measurement error and correlation coefficients. BMJ 1996;313:41-42.
20. Cox G, Thomson NC, Rubin AS, Niven RM, Corris PA, Siersted HC, Olivenstein R, Pavord ID, McCormack D, Chaudhuri R, et al.; AIR Trial Study Group. Asthma control during the year after bronchial thermoplasty. N Engl J Med 2007;356:1327-1337.
21. Jones RL, Elliot JG, James AL. Estimating airway smooth muscle cell volume and number in airway sections. Sources of variability. Am J Respir Cell Mol Biol 2014;50:246-252.
22. Dournes G, Berger P, Laurent F. Airway compliance studied by lumen area changes alone cannot discriminate between collapsibility and elasticity. Am J Respir Crit Care Med 2013;187:107-108.
23. Montaudon M, Lederlin M, Reich S, Begueret H, Tunon-de-Lara JM, Marthan R, Berger P, Laurent F. Bronchial measurements in patients with asthma: comparison of quantitative thin-section CT findings with those in healthy subjects and correlation with pathologic findings. Radiology 2009;253:844-853.
24. Bara I, Ozier A, Tunon de Lara JM, Marthan R, Berger P. Pathophysiology of bronchial smooth muscle remodelling in asthma. Eur Respir J 2010;36:1174-1184.
25. Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F, Wang L, Kirkesseli S, Rocklin R, Bock B, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 2013;368:2455-2466.
26. Gross AS, Eichelbaum M, Mörike K, Mikus G. Pharmacokinetics and pharmacodynamics of R- and S-gallopamil during multiple dosing. Br J Clin Pharmacol 2000;49:132-138.
27. Schweizer MW, Brachmann J, Kirchner U, Walter-Sack I, Dickhaus H, Metze C, Kübler W. Heart rate variability in time and frequency domains: effects of gallopamil, nifedipine, and metoprolol compared with placebo. Br Heart J 1993;70:252-258.